Milestone Pharmaceuticals Inc. — Director's Dealing 2019

May 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Milestone Pharmaceuticals Inc. (MIST)
CIK: 0001408443
Period of Report: 2019-05-13

Reporting Person: FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-13	Common Shares	C	139849	—	Acquired	170416	Direct
2019-05-13	Common Shares	C	798974	—	Acquired	969390	Direct
2019-05-13	Common Shares	C	574292	—	Acquired	1543682	Direct
2019-05-13	Common Shares	C	437203	—	Acquired	1980885	Direct
2019-05-13	Common Shares	C	306092	—	Acquired	2286977	Direct
2019-05-13	Common Shares	P	433333	$15	Acquired	2720310	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-13	Series A-1 Preferred	$	C	139849	Disposed		Common Shares (139849)	Direct
2019-05-13	Series A-2 Preferred	$	C	798974	Disposed		Common Shares (798974)	Direct
2019-05-13	Series B Preferred	$	C	574292	Disposed		Common Shares (574292)	Direct
2019-05-13	Series C Preferred	$	C	437203	Disposed		Common Shares (437203)	Direct
2019-05-13	Series D-1 Preferred	$	C	306092	Disposed		Common Shares (306092)	Direct

Footnotes

F1: Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering.